期刊文献+

压力导丝在冠心病弥漫性长病变介入治疗中的应用 被引量:5

Application of pressure wire in intervention treatment of diffuse coronary artery
暂未订购
导出
摘要 目的探讨压力导丝测定心肌血流储备分数(FFR)在冠心病弥漫性长病变介入治疗中的应用。方法选取72例经冠状动脉造影(CAG)明确存在弥漫性长病变的冠心病患者,对照组35例(40处病变),依术者临床经验选择常规经皮冠状动脉介入治疗(PCI)或药物治疗;观察组37例(43处病变),通过压力导丝回撤技术测定FFR,观察FFR曲线是否存在明显压力"跳跃",对出现"跳跃"处的病变行介入治疗,对未见明显"跳跃"的病变行药物治疗。结果两组患者冠状动脉病变程度比较差异无统计学意义,对照组植入药物支架33个,观察组植入药物支架19个,差异具有统计学意义(P<0.05)。半年观察期中,观察组心绞痛发生率明显低于对照组,差异具有统计学意义(P<0.05),而主要不良心血管事件(MACE)发生率两组差异无统计学意义。结论 FFR指导下PCI治疗冠心病弥漫性病变安全有效,减少了支架植入数量,且具有良好的预后。 Objective To investigate the application effects of fractional flow reserve(FFR)detected by pressure wire in the intervention treatment of diffuse coronary artery.Methods The study selected 72 patients with diffuse coronary artery detected by cardioangiography,35 cases(40 lesions)received general percutaneous coronary intervention(PCI)or medication with clinical experience as control group,37cases(43lesions)received PCI as FFR with leaping and medication as FFR without leaping,FFR was detected by pressure wire pull back method as observation group.Results There were no differences in lesion degree of coronary artery between two groups.33 drug eluting stents(DES)were used in control group and 19 DES were used in observation group with statistic significance(P〈0.05).In the half year's follow-up,the occurrence of angina pectoris in observation group was lower than that of control group(P〈0.05),but there were no differences in major adverse cardiovascular events(MACE)incidences between two groups.Conclusion The PCI treatment under the guidance of FFR for diffuse coronary artery lesion is safe and useful,which can reduce implanted stents with satisfactory prognosis.
出处 《临床荟萃》 CAS 2015年第7期755-757,共3页 Clinical Focus
关键词 冠状动脉疾病 压力导丝 血流储备分数 coronary disease pressure wire fractional flow reserve
  • 相关文献

参考文献12

  • 1孙丽杰,米琳,崔呜,郭丽君,张永珍,张福春,牛杰,李海燕,王贵松,韩江莉,高炜,李丹,李翠萍.冠状动脉临界病变定量冠状动脉造影参数与心肌流量储备分数的关系[J].中华心血管病杂志,2012,40(9):742-746. 被引量:10
  • 2Dias CC, Marcus P, Bettencourt N, et al. Value of fractional flowreservein the management of patients with moderate coronary stenosis[J].Rev Port Cardil, 2004,23 : 1409-1416.
  • 3Puymirat E,Muller O,Sharif F,et al. Fractional flow reserve: concepts, applications and use in France in 2010 [J]. Arch Cardiovasc Dis, 2010,103(11-12) : 615-622.
  • 4Wijns W,Kolh P, Danchin N, et al. Guidelines on myocardial revascularization,task force on myocardial revascularization of the European society of cardiology (ESC) and the European association for cardio-thoracic surgery (EACTS)[J].Eur Heart J,2010,31(20) :2501-2555.
  • 5何晓全,刘梅林.中国冠心病防治策略[J].中国全科医学,2015,18(2):239-240. 被引量:195
  • 6张卫泽,马凌,陈永清,敖雪玲,李涛,郭亮,陈敏,张玉秀.冠状动脉造影在左心室导线植入中的应用[J].中华心律失常学杂志,2010,14(4):311-313. 被引量:3
  • 7彭长农,王小庆,廖志勇,冼展超.压力导丝在冠状动脉临界病变处理中的意义[J].医学影像学杂志,2011,21(12):1811-1814. 被引量:3
  • 8杜纪兵,刘寅,高静,陈树涛,丛洪良.经皮冠状动脉介入治疗术后再狭窄临床危险因素的分析[J].临床荟萃,2010,25(11):974-976. 被引量:4
  • 9Manka R, Wissmann L, Gebker R, et al. Multicenter evaluation of dynamic three-dimensionalmagnetic resonance myocardial perfusion imaging for the detection of coronaryartery disease defined by fractional flow reserve[J]. Circ Cardiovasc Imaging, 2015,8 (5), pii : e003061.
  • 10Diaz-Zamudio M, Dey D, Sehuhbaeck A, et al. Automated quantitative plaque burden from coronary CT angiography noninvasively predicts hemodynamic significance by using fractional flow reserve in intermediate coronary lesions[J]. Radiology, 2015 April 17 : 141648. [Epub ahead of print].

二级参考文献35

  • 1华伟,王方正,朱丽,张澍,陈柯萍,牛红霞,陈新.117例双心室再同步起搏器植入术并发症分析[J].中华心律失常学杂志,2004,8(4):252-254. 被引量:34
  • 2杨西云,郭涛,韩明华.双心室起搏左心室导线植入失败原因分析[J].中华心律失常学杂志,2005,9(6):408-408. 被引量:8
  • 3Dehmer GJ,Smith KJ. Drug-eluting coronary artery stents[J]. Am Fam Physician,2009,80(11):1245-1251.
  • 4Moses JW, Stone GW, Nikolsky, et al. Drug-eluting stents in the treatment of intemediate lesions pooled analysis from four randomized trails[J]. J Am Coll, 2006,47 (11 ) : 2164-2171.
  • 5Hur SH, Cho YK, Nam CW, et al. Comparison of long-term outcomes following sirolimus-eluting stent vs paclitaxel-eluting stent implantation in patients with long calcified coronary lesions[J]. Clin Cardiol, 2009,32 ( 11 ): 633-638.
  • 6Hoffmann R, Mintz GS, Mehran R, et al. Tissue proliferation within and surrounding Palmaz-Schatz stents is dependent on the aggressiveness of stent implantation technique[J]. Am J Cardiol. 1999,83(8):1170-1174.
  • 7Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery[J]. N Engl J Med, 2003,349 (14) : 1315-1323.
  • 8West NE, Ruygrok PN, Disco CM, et al. Clinical and angiographic predictors of restenosis after stent deployment in diabetic patients[J]. Circulation,2004,109(7):867-873.
  • 9Abizaid A, Costa MA, Blanchard D, et al. Sirolimus eluting stents inhibit neointimal hyperplasis in diabetic patients. Insights from the RAVEl. trial[J]. Eur Heart J, 2004,25 (2): 107-112.
  • 10Schofer J, Schluter M, Gershlick AH, et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS)[J ]. Lancet, 2003, 362 ( 9390 ) 1093-1099.

共引文献210

同被引文献36

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部